We are targeting HIV at multiple key nodes to pursue treatment, prevention, and cure.
Deeks et al. Nature Reviews
INSTI - ULA
IND Enabling Studies
Ultra-long-acting (ULA) injectable agent targeting HIV integrase
NNRTI
NRTI
CRISPR Editing
Our long-acting platform technology extends beyond virology.
Opioid Use Disorder
Undisclosed CNS Disorder
© 2022 Exavir Therapeutics. All rights reserved.
.svg)